Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027143 · ClinicalTrials.gov registry record · Phase 2
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
A Phase 2 study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 143
- Enrollment target
NCT01027143: Completed Phase 2 study, sponsored by Nemours Children's Clinic.
NCT01027143 is a Phase 2 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 143 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01027143, a Phase 2 study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 143 participants
- Enrollment target
Study Summary
This project will assess the effectiveness of omega-3 fatty acid supplementation in controlling asthma symptoms among obese asthmatics, and will assess if a person's genes influence response to treatment (personalized medicine). This project may improve our ability to treat asthma and our understanding of the link between obesity and asthma.
Primary Outcome
The ACQ ranges from 0 to 6 (higher values indicate worse asthma control). A score greater than 1.25 in children is considered poor asthma control, and a change of 0.4 or greater is considered clinical meaningful.
Interventions
- DIETARY_SUPPLEMENT omega-3 polyunsaturated fatty acids
- DRUG Omega-3 Fatty Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2010-07 |
| Est. Completion | 2016-10-22 |
| Phase | Phase 2 |
What the finished NCT01027143 record still lists
NCT01027143 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which omega-3 polyunsaturated fatty acids is the first listed.
NCT01027143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01027143 about?
NCT01027143 is a clinical study titled "Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids". This project will assess the effectiveness of omega-3 fatty acid supplementation in controlling asthma symptoms among obese asthmatics, and will assess if a person's genes influence response to treatment (personalized medicine). This project may improve our ability to treat asthma and our understand...
What is the current status of trial NCT01027143?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 143 participants. The study started on 2010-07. Estimated completion is 2016-10-22.
What interventions are being tested in trial NCT01027143?
The interventions under investigation include: omega-3 polyunsaturated fatty acids (DIETARY_SUPPLEMENT), Omega-3 Fatty Acid (DRUG).
Who is sponsoring clinical trial NCT01027143?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01027143's enrollment target sits among peer trials
143 507th of 2000 higher than 1,494 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia